GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of reading telehealth threads from 2024 and half of it aged badly — 39 comments in the full submission. View in context.
2.7k
c/compounding·submitted 2 years ago by u/marit_mwangi

reading telehealth threads from 2024 and half of it aged badly

Pricingbranch of 7 comments

Long-ish post, sorry. tl;dr at the bottom. I have been tracking state board against eGFR for 35 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…

Read the full submission and all 39 comments →

This branch

7 comments, started 2 years ago
u/bilal_osei41 points·2 years ago

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
u/camila_sandvik27 points·2 years ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/rania_diallo8 points·2 years ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/lipid_panel_larrybloodwork9 points·2 years ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/julia_erdogan7 points·2 years ago

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
u/dario_stanescu5 points·2 years ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/lift_heavy_thingsresistance training14 points·2 years ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →